Rakipovski, G., Rolin, B., Nøhr, J., Klewe, I., Frederiksen, K. S., Augustin, R., . . . Knudsen, L. B. (2018). The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways. JACC. Basic to translational science, 3(6), 844-857. https://doi.org/10.1016/j.jacbts.2018.09.004
Chicago-Zitierstil (17. Ausg.)Rakipovski, Günaj, et al. "The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis In ApoE−/− and LDLr−/− Mice By a Mechanism That Includes Inflammatory Pathways." JACC. Basic to Translational Science 3, no. 6 (2018): 844-857. https://doi.org/10.1016/j.jacbts.2018.09.004.
MLA-Zitierstil (9. Ausg.)Rakipovski, Günaj, et al. "The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis In ApoE−/− and LDLr−/− Mice By a Mechanism That Includes Inflammatory Pathways." JACC. Basic to Translational Science, vol. 3, no. 6, 2018, pp. 844-857, https://doi.org/10.1016/j.jacbts.2018.09.004.